The Pharmagellan Guide to Biotech Forecasting and Valuation
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.• Vetted benchmarks for key drivers of income, expenses, and valuation.• Proprietary analyses by Pharmagellan's experienced consulting team.• More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.Whet…
Mehr
CHF 130.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
Weitere Autoren: Robey, Seth / Matthews, Andrew
- ISBN: 978-0-9984075-0-0
- EAN: 9780998407500
- Produktnummer: 35433458
- Verlag: Pharmagellan, LLC
- Sprache: Englisch
- Erscheinungsjahr: 2017
- Seitenangabe: 138 S.
- Masse: H22.9 cm x B15.2 cm x D0.7 cm 212 g
- Abbildungen: Paperback
- Gewicht: 212
1 weiteres Werk von Frank S. David:
Bewertungen
Anmelden